Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the women's health initiative observational cohort

Clinical Chemistry

Volumn 55, Issue 2, 2009, Pages 351-360

  Lee, Cathy C ^a,b   You, Nai Chieh Yuko ^c   Song, Yiqing ^d   Hsu, Yi Hsiang ^e   Manson, Joann ^d   Nathan, Lauren ^a   Tinker, Lesley ^f   Liu, Simin ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PLASMA PROTEIN;

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; OBSERVATIONAL STUDY; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; HAPLOTYPES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; UNITED STATES;

EID: 59649108269     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.117176     Document Type: Article

References (35)

1. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004;53: 693-700.
2. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
3. Liu S, Tinker L, Song Y, Rifai N, Bonds DE, Cook NR, et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007;167:1676-85.
4. Zee RY, Germer S, Thomas A, Raji A, Rhees B, Ridker PM, et al. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis 2008;197:931-6.
5. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351:2599-610.
6. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
7. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8.
8. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
9. Ridker PM, Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Investig Med 1998;46:391-5.
10. Ridker P, Rifai N, Koenig W, Blumenthal RS. C-reactive protein and cardiovascular risk in the Framingham Study. Arch Intern Med 2006;166:1327- 8.
11. Pai JK, Mukamal KJ, Rexrode KM, Rimm EB. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PLoS ONE 2008;3:e1395.
12. Ranjit N, Diez-Roux AV, Shea S, Cushman M, Ni H, Seeman T. Socioeconomic position, race/ ethnicity, and inflammation in the multi-ethnic study of atherosclerosis. Circulation 2007;116:2383-90.
13. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004;93:1238 -42.
14. Albert MA, Ridker PM. C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation 2006;114:e67-74.
15. Miller DT, Zee RY, Suk DJ, Kozlowski P, Chasman DI, Lazarus R, et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005;69:623-38.
16. Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, et al. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 2007;56:872-8.
17. Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ, et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 2005;366:1954-9.
18. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005;77:64-77.
19. Lange LA, Burdon K, Langefeld CD, Liu Y, Beck SR, Rich SS, et al. Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study. Ann Hum Genet 2006; 70:71 7-25.
20. Crawford DC, Yi Q, Smith JD, Shephard C, Wong M, Witrak L, et al. Allelic spectrum of the natural variation in CRP. Hum Genet 2006;119:496-504.
21. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61-109.
22. Hao K, Liu S, Niu T. A sparse marker extension tree algorithm for selecting the best set of haplotype tagging single nucleotide polymorphisms. Genet Epidemiol 2005;29:336 -52.
23. A haplotype map of the human genome. Nature 2005;437:1299-320.
24. Wang L, Liu S, Niu T, Xu X. SNP Hunter: a bioinformatic software for single nucleotide polymorphism data acquisition and management. BMC Bioinformatics 2005;6:60.
25. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
26. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
27. Kraft P, Cox DG, Paynter RA, Hunter D, De Vivo I. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 2005;28: 261-72.
28. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279-84.
29. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, Tracy RP. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001;154:681-9.
30. Wolford JK, Gruber JD, Ossowski VM, Vozarova B, Antonio TP, Bogardus C, Hanson RL. A C- reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 2003;78:136-44.
31. Chen J, Zhao J, Huang J, Su S, Qiang B, Gu D. -717A >G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study. J Mol Med 2005;83:72-8.
32. Szalai AJ, Wu J, Lange EM, McCrory MA, Lange-feld CD, Williams A, et al. Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 2005;83:440-7.
33. Serre D, Montpetit A, Pare G, Engert JC, Yusuf S, Keavney B, et al. Correction of population stratification in large multi-ethnic association studies. PLoS ONE 2008;3:e1382.
34. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000;155:945-59.
35. Hao K, Li C, Rosenow C, Wong WH. Detect and adjust for population stratification in population- based association study using genomic control markers: an application of Affymetrix Genechip Human Mapping 10K array. Eur J Hum Genet 2004;12:1001-6.